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SummAry
The aim of this study was to investigate the presence of mitochondrial DnA (mtDnA) alterations and metabolic dysfunctions in patients 
with presbyacusis, and to discover correlations between presbyacusis and the degree of hearing loss and mitochondrial damage. Seventy pa-
tients with presbyacusis were examined, including 40 Egyptian patients and 30 italian patients. Forty eight normal subjects were included 
as control group, including 24 Egyptians and 24 italians. There was no common point mutation, and A1555g, A3243g, A7445g not were 
detected in any patients or controls. haplogroup u was significantly common in patients in comparison to controls. mutation of antioxidant 
genes (gSTT1, gSTm1) were significantly present in only italian patients compared to italian controls.
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riASSunTo
Lo scopo dello studio è stato quello di indagare la presenza di alterazioni del DNA mitocondriale (mtDNA) in pazienti affetti da presbiacu-
sia e di evidenziare eventuali correlazioni tra la presbiacusia, il grado di deficit uditivo e le alterazioni mitocondriali. Sono stati esaminati 
settanta pazienti affetti da presbiacusia, tra cui quaranta pazienti egiziani e trenta italiani. Quarantotto soggetti normoacusici sono stati 
utilizzati come gruppo di controllo, tra cui ventiquattro soggetti egiziani e ventiquattro italiani. In nessun paziente, né nei controlli, ab-
biamo identificato le mutazioni puntiformi A1555G, A3243G, A7445G. L’aplogruppo U era significativamente più comune nel gruppo di 
pazienti in confronto al gruppo dei controlli. La mutazione dei geni Antioxidant (GSTT1, GSTM1) sono state riscontrate più comunemente 
nei pazienti italiani rispetto ai controlli italiani, in maniera significativa.
PArolE ChiAvE: Presiacusia • Mitocondria • Aplotipi • Geni antiossidanti
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Introduction
Presbyacusis is a complex disorder, influenced by genetic, 
environmental/lifestyle and stochastic factors. Approxi-
mately, 13% of those over age 65 show advanced signs of 
presbyacusis. By the middle of 21st century, the number 
of people with hearing impairment will have increased by 
80%, partly due to an aging population, and partly to the 
increase of social, military and industrial noise 1.
According to Portmann and Portmann 2, presbyacusis is 
a biologic phenomenon that no one can escape, starting 
at 20-30 years of age, and becomes socially bothersome 
when the person reaches 40-50 years. Early diagnosis and 
intervention in presbyacusis are paramount to provide the 
elderly with a good quality of life.
Even though all individuals show a steady decline in hear-
ing ability with ageing, there is a large variation in age of 
onset, severity of hearing loss and progression of disease, 
which results in a wide spectrum of pure-tone threshold 
patterns and word discrimination scores. Presbyacusis has 
always been considered to be an incurable and an unpre-
ventable disorder, thought to be part of the natural process 
of ageing, but nowadays, it is recognized as a complex 
disorder, with both environmental and genetic factors 
contributing to its aetiology. This also means that it is not 
an inevitable disorder, and presbyacusis should be consid-
ered as any other complex disease with a possible treat-
able and/or preventable nature. Scientific research should 
aim at the elucidation of the contributing factors 3.
Forward genetic examination is a promising approach. 
Isolating all the genes in the human genome, as well as 
identifying and cataloguing the functional variants within 
them in the human population, will allow assessment of 
the impact of genotype on phenotypic outcome of inter-
est. Additionally, complementary strategies, based on 
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functional genomics technology involving microarrays 
and proteomics, can be used to develop predictors of dis-
ease susceptibility based on biological pathways physi-
ologically relevant to presbyacusis. Nevertheless, choices 
in study designs will still be a major factor in the prob-
ability of success. Determination of the genetic variants 
involved in presbyacusis should provide new insights into 
the disorder mechanism, which may uncover new leads 
for pharmaceutical intervention and could result in the 
development of screening kits to identify individuals at 
increased risk 4.
To date, genetic analysis of presbyacusis has been lim-
ited. However, with recent major advances in hearing 
research, the human genome sequence completed and 
a comprehensive map of human genetic variation (Hap 
Map) available, together with a growing awareness of the 
importance of healthy ageing as global populations begin 
to age, a search for susceptibility alleles for presbyacusis 
can be justifiably undertaken 5.
Screening of cochlear tissue from blood of patients with 
presbyacusis have identified mtDNA mutations, which 
could be related to age-related hearing loss. Many mito-
chondrial mutations cause defects in mitochondria from 
tissues such as lymphocytes and fibroblasts, yet the only 
phenotype associated with these mutations is hearing 
loss  6. This tissue specificity may be the result of envi-
ronmental factors. Tissue-specific patterns of gene ex-
pression are also likely to influence the effect of mtDNA 
mutations, with several examples of nuclear background 
affecting the defect caused by a mutation of the mtDNA 7.
The A3243G mutation, a variant located in the mitochon-
drial tRNALeu (UUR) gene and also known as MTTL1, 
is one of the most frequent heteroplasmic mitochondrial 
mutation  8. Individuals carrying the A3243G mutation 
may manifest either as syndromic or non-syndromic mi-
tochondrial disorders, and others may be asymptomatic. 
The most frequent syndromic manifestation of this muta-
tion is mitochondrial encephalopathy, lactic acidosis and 
stroke-like episodes syndrome (MELAS) 9. The original 
disorder in which the mutation was found is MELAS, but 
the majority of patients with the A3243G mutation show 
other clinical symptoms such as maternally inherited dia-
betes and deafness (MIDD), progressive external ophthal-
moplegia (PEO) or other symptoms which include pres-
byacusis, kidney disease, cardiomyopathy, neuropathy or 
endocrinopathies different from diabetes 10.
The A7445G mutation, identified as T7445C in some ear-
lier papers, was first described in a Scottish family and 
confirmed and established in two unrelated pedigrees 
from New Zealand and Japan 11. The penetrance of this 
mutation in the Scottish pedigree is quite low, while in 
the New Zealand and Japanese pedigrees is very high. 
Thus, mutation of A7445G itself may not be sufficient to 
cause hearing loss, but requires additional genetic or en-
vironmental factors, which seem to be rare in the Scottish 
pedigree and common in the New Zealand and Japanese 
pedigrees 12.
The A1555G mutation in the mitochondrial 12S rRNA 
gene is one of the most common causes of sensorineural 
hearing loss and aminoglycoside-induced deafness. This 
mutation was first discovered in a large Arab-Israeli fam-
ily, and subsequently found in various ethnic groups from 
Europe, Asia and Africa, with a variable prevalence. In 
the absence of aminoglycoside exposure, the phenotype 
observed is extremely variable in terms of the severity of 
hearing loss and age of onset. Moreover, a significant por-
tion of individuals has normal hearing for their entire life. 
In many families with the A1555G mutation, a mild and 
progressive hearing loss occurs even in the absence of ex-
posure to aminoglycosides. The hearing loss in affected 
cases shows a varied age of onset and severity, whereas 
others show a slow, progressive hearing loss beginning in 
their 40s, often preceded by tinnitus 13.
Mitochondrial DNA (mtDNA) “polymorphisms” are ma-
ternally transmitted and typically reflect different ethnic 
backgrounds. Specific mtDNA polymorphisms have now 
been classified into a number of specific mitochondrial 
haplogroups. MtDNA haplogroups, determined by poly-
morphisms that occurred tens of thousands of years ago, 
are today high-prevalence population-specific substitu-
tions. mtDNA has been used for a couple of decades as a 
molecular marker in population genetics 12.
Certain mtDNA haplogroups may increase the risk of 
presbyacusis in some individuals, and mtDNA haplo-
groups are genetic markers for presbyacusis. The mtDNA 
haplogroups U and K are independent genetic markers for 
moderate to severe presbyacusis and may modify suscep-
tibility associated with some known risk factors, but the 
precise mechanism underlying how mtDNA haplogroups 
increase genetic risk for presbyacusis remains to be clari-
fied. If these findings are confirmed, introduction of pre-
ventive strategies to minimize environmental causes could 
be implemented to reduce the overall risk of a genetically 
susceptible individual of developing presbyacusis 14.
Enzymes involved in glutathione metabolism (glutathione 
S-transferase, glutathione peroxidase, glutathione reduc-
tase) and enzymes involved in the breakdown of super-
oxide anions (catalase) have been suggested to be linked 
with presbyacusis  15. Glutathione S-transferase comprises 
several gene classes including GSTM and GSTT that show 
genetic variability in humans. Individuals who have null 
genotypes for GSTM1 and GSTT1 cannot conjugate me-
tabolites specific for these enzymes. These individuals are 
thus thought to be more prone to damage caused by oxida-
tive stress and possibly more susceptible to presbyacusis 16.
In this study, the aim was to detect the presence of mtD-
NA alterations and mitochondrial metabolic dysfunctions 
in patients with presbyacusis, and to discover any correla-
tions between presbyacusis and the degree of hearing loss 
and mitochondrial damage.
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Materials and methods
Patients
Seventy patients with presbyacusis were examined, in-
cluding 40 Egyptian patients and 30 Italian patients. The 
Egyptian patients were examined in the clinic of Audiol-
ogy Unit, ENT Department, Assiut university Hospital, 
Egypt. Italian patients were examined in the clinic of the 
Audiology Unit, ENT Department, Pisa University, Italy.
Each patient had to fulfil the following criteria: Age above 
40 years; bilateral more or less symmetrical sensorineu-
ral hearing loss, pure tone hearing threshold poorer to the 
normative values per age, determined by international 
committees; absence of any known cause of sensorineural 
hearing loss; absence of exposure to ototoxic drugs, oto-
logic diseases, cranial trauma, acoustic trauma, chronic 
exposure to noise; and absence of any other pathology po-
tentially correlated to sensorineural hearing loss 17.
Forty eight normal individuals were included as control 
group, including 24 Egyptians and 24 Italians, with the 
following criteria: age above 40 years; pure tone hearing 
threshold within normal values per age as determined by 
international committees.
Informed consent was obtained from personal partici-
pants.
Audiological evaluation
All individuals in the study and control groups were sub-
jected to:
•	 full	medical	history,	including	pedigree	chart;
•	 ENT	examination;
•	 pure	 tone	 audiometry	 with	 speech	 audiometry	 and	
tympanometry with measurement of the stapedial re-
flex. Of those volunteers who passed medical exclu-
sion criteria, air conduction thresholds were measured 
at 250, 500, 1000, 2000, 3000, 4000 and 8000 Hz and 
bone conduction thresholds at 500, 1000, 2000 and 
4000 Hz, according to clinical standards (ISO 8253-1, 
1989).
All audiograms were categorized according to sever-
ity of hearing loss into five categories: mild, moderate, 
moderately severe, severe and profound hearing loss; ac-
cording to the mean of thresholds at 500,1000,2000 and 
4000 Hz 17 (Table I).
Molecular evaluation
Peripheral blood was obtained from all participants. 
About 5 ml blood were obtained in suitable EDTA tubes
DNA was isolated from blood using a Nucleospin©Tissue 
kit (2006). mtDNA point mutations were determined by 
PCR-RFLP analysis. A set of primers, that amplifies all the 
tRNA coding regions for screening of A1555G, A3243G 
and A7445G point mutations were used. Reactions are per-
formed in 25 µl of 10 mM Tris-HCl (pH 8.9) containing 
0.4 µM each of the forward and reverse primers, 1.5 mM 
MgCl
2
, 0.2 mM each of dATP, dGTP, and dTTP, 0.02 mM 
dCTP, 1 µCi of α-32[P] dCTP, and 1.25 U of Taq DNA pol-
ymerase (Roche, Indianapolis, IN). PCR conditions were: 
94°C for 3 min, followed by 35 cycles of 94°C for 1 min, 
55°C for 1 min, 72°C for 30 sec, and a final extension step 
at 72°C for 7 min. Samples were denatured and separated 
on a 6% MDE polyacrylamide gel (BME, Rockland, ME) 
with 5% glycerol, according to the manufacturer’s proto-
col. Confirmations of single-stranded DNA are visualized 
by autoradiography using BioMax film (Kodak, Rochester, 
NY). Samples with abnormal patterns were directly se-
quenced using the ABI PRISM Big Dye Terminator Cycle 
Sequencing Ready Reaction Kit and a 310 Automatic Se-
quencer (Applied Biosystems, Foster City, CA).
Eleven mtDNA haplogroups (H, T, J, U, K, V, I, W, X, 
O, L) were categorized by the presence or absence of 
the well-defined restriction enzyme recognition sites as 
determined by PCR and RFLP analysis, in all patients 
and controls 18, (Revised Cambridge Reference Sequence 
“rCRS”).
Table I. Categories of the audiogram according to configuration.
Category Definition
Flat Audiogram where the difference between the mean of 250/500 Hz thresholds, the mean of 1/2 kHz thresholds and the mean of 
4/8 kHz thresholds, is less than 15 dB
High frequency
gently sloping
(HFGS)
Audiogram where the difference between the mean of 500 Hz/1 kHz thresholds and the mean of 4 kHz/8 kHz thresholds is greater 
than 15 dB and less than 29 dB
High frequency
steeply sloping
(HFSS)
Audiogram where the difference between the mean of 500 Hz/1 kHz thresholds and the mean of 4 kHz/8 kHz thresholds is greater 
than 30 dB
Low frequency
ascending (LFA)
Audiogram where the difference between the poorer low frequency thresholds and better high frequency ones is greater than 15 dB
Mid frequency
U-shape (MFU)
Audiogram where the difference between the poorest thresholds in the mid-frequencies and those at higher and lower frequencies 
is greater than 15 dB
Mid frequency
reverse U-shape
(MFRU)
Audiogram where the difference between the best thresholds in the mid-frequencies and those at higher and lower frequencies is 
greater than 15 dB
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The genetic polymorphism analysis for the GSTM1 and 
GSTT1 genes was determined using the multiplex PCR 
procedure of Abdel-Rahman  19. Isolated DNA (40  ng) 
was amplified in a 25  µl reaction mixture containing 
25  pmol of each of the following: GSTM1 primers of 
5’-GAA CTC CCT GAA AAG CTA AAG C-3’, 5’-GTT 
GGG CTC AAA TAT ACG GTG G-3’ and GSTT1 prim-
ers of 5’-TTC CTT ACT GGT CCT CAC ATC TC-3’, 5’-
TCA CCG GAT CAT GGC CAG CA-3’. As an internal 
control exon 7 of the CYP1A1, genes were co-amplified 
using the primers 5’-GAA CTG CCA CTT CAG CTG 
TCT-3’ and 5’-CAG CTG CAT TTG GAA GTG CTC-
3’ in the presence of 200 µmol dNTP (deoxynucleotide 
triphosphate), 25 µl 10 × PCR buffer, 1.5 mM MgCl
2
, 
and 1 U Taq polymerase. The PCR conditions consisted 
of an initial melting temperature of 94°C (5  min) fol-
lowed by 35 cycles of melting (94°C, 2  min) and an-
nealing (59°C, 1 min), and an extension step (72°C) for 
10 min terminated the process. The PCR products were 
then analyzed electrophoretically on an ethidium bro-
mide stained 1.5% agarose gel.
Data were analyzed by using the SPSS-11 statistics pro-
gramme to detect haplogroup distribution and differences 
between patient and control groups for point mutations 
and antioxidant defects.
Results
The study included 70 patients with presbyacusis. Forty 
patients were Egyptian and 30 were Italian. The study in-
cluded also 48 subjects as a control group; 24 were Egyp-
tian and 24 were Italian.
Thirty-six patients were male, and 34 were female. Twen-
ty four patients had positive history of consanguinity be-
tween their parents, and they were all Egyptian patients. 
Twenty-nine patients had familial history of presbyacu-
sis; 25 were Egyptian, and only four were Italian. Fig. 1 
shows distribution of the patient group according to age. 
Mean (±  SD) age for Egyptian patients was 61.2  ±  9.0 
years, while the mean age for Italian patients was 
69.1 ± 7.5 years. Mean (± SD) age for Egyptian controls 
was 54 ± 6.8 years, and the mean age for Italian controls 
was 60.1 ± 7.5 years. There was no statistically significant 
difference between the mean age in Egyptian and Italian 
patients.
Audiological results
Patients were classified according to the degree of hear-
ing loss into five categories: mild, moderate, moderately 
severe, severe and profound hearing loss (Fig.  2). The 
mean (± SD) hearing threshold for Egyptian patients was 
62.7 ± 4.7 dB HL, while the mean hearing threshold for 
Italian patients was 67.1 ± 8.2 dB HL. There was no sta-
tistical significant difference between the mean hearing 
threshold in Egyptian and Italian patients.
The control groups including Egyptians and Italian sub-
jects had normal peripheral hearing.
Patients were also classified according to the shape of 
audiograms into five categories: flat, HFGS, HFSS, LFA, 
MFU and MFRU (Fig. 3).
Molecular results
Point mutations in A1555G, A3243G, and A7445G were 
not detected in any subject in either the study or control 
groups.
After identification of haplogroup distribution, the hap-
logroup  U was the most common haplogroup (32.5%) 
among Egyptian patients, followed by haplogroup  H 
(27.5%), haplogroup I (20%) and haplogroup T (7.5%). In 
Italian patients, haplogroup H was the most common hap-
logroup (30%), followed by haplogroup U (23.3%) hap-
Fig. 1. Distribution of patients according to age.
Fig. 2. Classification of patients according to degree of hearing loss.
Fig. 3. Classification of patients according to shape of audiogram.
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logroups T, I and O (13.3% each). In Egyptian controls, 
haplogroup L was the most common haplogroup (33.3%), 
followed by haplogroups H and T (20.8% each) and hap-
logroup U (12.5%). In Italian controls, haplogroup H was 
the most common (58.3%), followed by haplogroups T, I, 
W and O (8.3% each) (Table II).
Genetic polymorphism analysis for the GSTM1 and 
GSTT1 genes was performed in all patients and control 
subjects. The polymorphism analyzed in the GSTM1 
and GSTT1 genes was the null geneotype. For GSTM1, 
this mutation was identified in 25 patients (35%) (10 
Egyptians, 15 Italians). Only four subjects in the con-
trol group (8.3%) had this mutation, and they were all 
Egyptians. There was a statistically significant dif-
ference (p  <  0.001) between the patient and control 
groups, and between the Italian patient and control 
groups, but no statistically significant difference was 
detected between Egyptian patients and control groups 
(Table III, Fig. 4).
For GSTT1 gene, this mutation was identified in 21 pa-
tients (30%) (10 Egyptian patients, 11 Italian patients). 
Only nine control individuals (18.75%) had this mutation 
(six Egyptians and three Italians). There was statistically 
significant difference between both patient and control 
groups in total, and between the Italian patient and con-
trol groups, but no significant difference was detected be-
tween the Egyptian patients and control groups (Table IV, 
Fig. 5).
Table IV. GSTT1 gene mutation in study groups.
Group Positive GSTT1in patients
Positive GSTT1
in controls p value
Total 21/70 (30%) 9/48 (18.75%) < 0.001
Egyptians 10/40 (25%) 6/24 (25%) Not significant
Italians 11/30 (36.6%) 3/24 (12.5%) < 0.001
Fig. 5. Genetic polymorphism analysis for GSTT1.
After statistical analysis of the results with a One Way 
Anova test, no statistical significance was detected be-
tween groups (one way Anova > 0.05)
After analysis there was no correlation between separate 
groups, and no significant correlations were identified be-
tween any audiological or molecular variables including 
age, degree of hearing loss, shape of audiogram, haplo-
group distribution, GSTM1 and GSTT1 mutations among 
Egyptian, Italian and all patients (Table V).
Table II. Distribution of haplogroups in the study and control groups.
Group H T J U K V I W X O L
Eg patients 11 (27.5%)
3
(7.5%)
1
(2.5%)
13
(32.5) 0 (0%) 0 (0%)
8
(20%) 0 (0%) 1 (2.5%)
2
(5%) 1 (2.5%)
It patients 9 (30%) 4 (13.3%) 1(3.3%) 7 (23.3%) 0 (0%) 0 (0%) 4 (13.3%) 0 (0%) 1 (3.3%)
4
(13.3%) 0 (0%)
Eg controls 5 (20.8%) 5 (20.8%) 0(0%) 3 (12.5%) 0 (0%) 0 (0%)
1
(4.1%) 1 (4.1%) 0 (0%) 
1
(4.1%) 8 (33.3%)
It controls 14 (58.3%)
2
(8.3%)
0
(0%) 1 (4.1%) 0 (0%) 1 (4.1%)
2
(8.3%) 2 (8.3%) 0 (0%)
2
(8.3%) 0 (0%)
Table III. GSTM1 gene mutation in study groups.
Group Positive GSTM1in patients
Positive GSTM1
in controls p value
Total 25/70 (35%) 4/48 (8.3%) < 0.001
Egyptian 10/40 (25%) 4/24 (16.6%) Not significant
Italians 15/30 (50%) 0/24 (0%) < 0.001
Fig. 4. Genetic polymorphism analysis for GSTM1.
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Discussion
The aim of epidemiological and genetic studies is to iden-
tify risk factors for presbyacusis, such as environmental 
factors or genetic factors. Presbyacusis is defined as a dis-
order, often quantified by a certain degree of hearing loss. 
In genetic terms, any study uses only ‘one’ phenotype to 
define the presence/ absence of hearing impairment due to 
ageing, and to determine possible risk factors or causes 20.
Most patients with presbyacusis have mild (28.5%) or 
moderate (32.8%) SNHL, and the ‘flat-configuration’ was 
most dominantly represented (35.7%), followed by HFSS 
(32.8%), while the ‘LFA’, ‘MFU’ and ‘MFRU’ configura-
tions were very rare (together less than 1%). These data 
agree with previous studies evaluating audiometric data 
on presbyacusis 21-23. As animal studies have shown that 
aging alone does not cause outer hair cell loss, some Au-
thors have emphasized that in humans, typically associ-
ated with a HFSS audiometric configuration, this has little 
to do with age.
It has been well documented that mutations in the 12S rR-
NA gene are hot spots that are antibiotic-induced and/or as-
sociated with presbyacusis, and several deafness-associated 
mtDNA mutations have been identified in this gene. These 
mutations in a highly conserved decoding site of 12S rRNA 
could associate with both aminoglycoside treatment and 
presbyacusis hearing loss in families with different ethnic 
backgrounds. The most common mutations in 12S rRNA 
causing presbyacusis are A1555G, A3243G and A7445G. 
These gene mutations have also been involved in amino-
glycoside-induced hearing impairment 15. The progressive 
breakdown of mitochondrial function with age might result 
in presbyacusis. Fischel-Ghodsian 24 reported mutations in 
the mitochondrially encoded cytochrome oxidase II gene in 
the auditory system of five patients with presbaycusis with 
large individual variability in both quantity and cellular lo-
cation of these mutations.
However in our study, these mutations were not detected 
in any patient. Recent studies indicate that the phenotypic 
expression of mtDNA mutations is highly variable, which 
indicates that these mutations may not be present, and 
some differences in either the nuclear gene content or ac-
tivity appears to contribute significantly to the biochemi-
cal defect 25. Because of heteroplasmy, the proportion of 
mutant mtDNA varies in cells/tissues of an individual, 
and affected organs can be variable in patients with the 
12S rRNA gene mutation 26.
We found a significantly higher prevalence of presbyacu-
sis in subjects with mtDNA haplogroups U and I in Egyp-
tian patients in comparison with Egyptian controls, while 
haplogroup  H was not statistically significant between 
Egyptian patients and controls. The Egyptian controls 
had significantly high prevalence of haplogroups L and T 
compared to Egyptian patients.
In Italian patients, haplogroup H is not statistically great-
er, while haplogroup U was significantly higher in com-
parison to Italian controls who had a significantly high 
prevalence of haplogroup H.
Different mtDNA haplogroups may cause mild delete-
rious bioenergetic abnormalities. Impairment in mito-
chondrial function due to mutations in the mitochondrial 
genome is associated with an insidious decline in physi-
ologic and biochemical performance that contributes to 
the aging process and to the ultimate death of the organ. 
There is a growing body of evidence to suggest that pres-
byacusis may be associated with a reduction in mitochon-
drial function. In keeping with this, mutations in mtDNA 
and reduced mitochondrial function have been reported in 
human models of presbyacusis 27.
Our findings suggest that haplogroup U may be used as 
a genetic marker for presbyacusis susceptibility. Our re-
sults further support the concept that certain mtDNA 
haplogroups may cause mild deleterious bioenergetic ab-
normalities rather than merely representing the “neutral” 
polymorphisms reflecting different ethnic backgrounds. It 
is possible that genetic variants in specific mtDNA haplo-
groups may impair respiratory chain function within the 
cochlea to increase the risk of developing presbyacusis.
A number of studies have suggested associations between 
various mtDNA haplogroups and a variety of medical 
conditions, including Parkinson’s disease, Alzheimer’s 
disease, occipital stroke in migraine, Leber hereditary 
optic neuropathy and multiple sclerosis. Of particular in-
terest, haplogroup U has previously been associated with 
occipital stroke, azoospermi and Alzheimer’s disease 28.
In many population studies, the prevalence of mtDNA 
haplogroup  U, reported from studies of European and 
North American populations 29 30, was similar to our data, 
Table V. Correlation between audiological and molecular variables in the study group.
Variable Age Degree ofhearing loss
Shape of 
audiogram
Haplogroup 
distribution GSTM1 mutation GSTT1 mutation
Age NS (p > 0.05) NS (p > 0.05) NS (p > 0.05) NS (p > 0.05) NS (p > 0.05)
Degree of
hearing loss NS (p > 0.05) NS (p > 0.05) NS (p > 0.05) NS (p > 0.05) NS (p > 0.05)
Audiogram shape NS (p > 0.05) NS (p > 0.05) NS (p > 0.05) NS (p > 0.05) NS (p > 0.05)
Haplogroup distribution NS (p > 0.05) NS (p > 0.05) NS (p > 0.05) NS (p > 0.05) NS (p > 0.05)
GSTM1 mutation NS (p > 0.05) NS (p > 0.05) NS (p > 0.05) NS (p > 0.05) NS (p > 0.05)
GSTT1 mutations NS (p > 0.05) NS (p > 0.05) NS (p > 0.05) NS (p > 0.05) NS (p > 0.05)
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suggesting that our results would likely be applicable to 
other populations.
Several antioxidant enzymes have been demonstrated to 
be active in the adult cochlea, for instance, enzymes in-
volved in glutathione metabolism and enzymes involved 
in the breakdown of superoxide anions. The GSTM1 and 
GSTT1 genes show genetic variability in humans. Geno-
types can be classified as null genotypes, heterozygotes, or 
wild type on the basis of whether they are homozygotes or 
heterozygotes. Approximately half of the white and black 
population are homozygotes for the deletion (null geno-
type). However, the percentage of the population carrying 
the null genotype varies in different geographic regions 
and ethnicities 31. Individuals who are null genotypes for 
GSTM1 and GSTT1 cannot conjugate metabolites specif-
ic for these enzymes. These individuals are thus thought 
to be more prone to damage caused by oxidative stress 
and possibly more susceptible to presbyacusis 32.
The present study highlights the genotypic variability of 
antioxidant enzymes among different ethnic populations. 
This study emphasizes ethnic discrepancies and how they 
relate to presbyacusis. These ethnic variabilities may play 
a role in genotype-phenotype associations, antioxidant 
enzymes and presbyacusis. This study demonstrated an 
increased risk of presbyacusis among Italian subjects car-
rying the GSTM1 and GSTT1 null genotype, but no in-
creased risk was demonstrated in Egyptian patients. Of 
clinical importance, recent studies in animals have shown 
the potential importance of antioxidant enzyme supple-
mentation in the prevention of presbyacusis. Bared  33 
showed an increased risk of presbyacusis among white 
subjects, and presbyacusis was more prevalent in white 
Hispanics than in white non-Hispanics.
These results are in contrast with previously published 
data. In a study of 68 white subjects of Turkish descent, 
Ates  16 did not find a statistically significant correla-
tion between individuals with a GSTM1 or GSTT1 null 
genotypes and presbyacusis. Similarly, Unal 34 found no 
association between the GSTT1 and the GSTM1 null 
genotypes and presbyacusis in white subjects of Turkish 
descent. However, In contrast to these studies, Bared 33, 
showed a clinically significant correlation for the devel-
opment of presbyacusis among subjects with the GSTT1 
mutant allele and the GSTM1 mutant allele.
In conclusion, our findings suggest that mtDNA haplo-
groups U are independent genetic markers for presbyacu-
sis and may modify susceptibility associated with some 
known risk factors. Mitochondrial DNA may play a role 
in the pathogenesis of presbyacusis, but our findings need 
to be corroborated by future studies to confirm the preva-
lence of mtDNA haplogroups in other populations of in-
dividuals affected with presbyacusis. The precise mech-
anism underlying how mtDNA haplogroups increase 
genetic risk for presbyacusis remains to be clarified. If 
these findings are confirmed, the introduction of preven-
tive strategies to minimize environmental causes could be 
implemented to reduce the overall risk in a genetically-
susceptible individual of developing presbyacusis.
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